UCLA Magnesium Formulation Athlete Study
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-35
SponsorUniversity of California, Los Angeles
About this trial
This randomized, double-blind, placebo-controlled trial will compare magnesium glycinate, magnesium L-threonate, and placebo in UCLA varsity athletes. Participants will complete a baseline monitoring period followed by 4 weeks of blinded nightly supplementation. WHOOP or study-approved wearable data will be used to evaluate sleep efficiency, total sleep time, sleep consistency, heart rate variability, resting heart rate, and recovery metrics. Baseline and final testing will assess selected reaction and physical performance outcomes. The primary outcome is change in WHOOP-derived sleep efficiency from baseline week to final treatment week.
Eligibility criteria
Qualifiers
Age 18 to 35 years.
Current UCLA varsity athlete.
Actively training or competing during the study period.
Willing to wear WHOOP or a study-approved wearable device continuously during baseline and treatment periods if wearable data are used.
Disqualifiers
Current magnesium supplementation without completion of an appropriate washout before baseline.
Current investigational drug or investigational supplement use.
Current use of prescription or over-the-counter sleep medications unless reviewed and permitted by the study clinician.
Diagnosed sleep disorder that, in the investigator's judgment, would confound outcomes or increase risk.
Trial design
Treatments tested in this trial
- Magnesium glycinate
- Magnesium L-threonate
- Placebo
Treatment groups
150 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov